In the face of the sudden monkeypox virus epidemic, many Chinese in vitro diagnostic enterprises responded quickly, completed the R & D and launched the monkeypox virus nucleic acid detection kit at the first time, effectively helping overseas to carry out the monkeypox virus prevention.

Biotech firms experienced a banner year in 2020.The COVID-19 pandemic highlighted the value of innovative medical solutions, leading to new opportunities for researchproduct approvaland funding

Becton Dickinson announced on Thursday that it has obtained the CE-IVD mark for a combined influenza, SARS-CoV-2 assay. The multiplexed RT-PCR test runs on the firm's high-throughput BD Cor system.

Roche on Wednesday said the company and its unit have developed three test kits to detect the monkeypox virus, as the disease spreads in regions outside Africa.

On May 23, 2022, Autobio Diagnostics Co., Ltd. announces CE mark for AutoMeloc Monkeypox nucleic acid detection kit (PCR-fluorescent probe method).

Global life sciences leader Cytiva is opening a new 7 400m2 manufacturing facility in Grens, Switzerland on May 31, 2022. The site will manufacture single use kits for the Sepax and Sefia cell processing systems, as well as consumables for Xuri cell expansion systems.

Aiforia Technologies said Wednesday that it has received CE-IVD marking for an artificial intelligence model that helps detect progesterone-positive tumor cells.

Hologic announced Wednesday it has obtained CE marking for its Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay, expanding its transplant pathogen monitoring menu on the automated, real-time PCR Panther Fusion system.

On May 19, the COVID-19 Antigen Rapid Test (colloidal gold method) independently developed by Guangzhou Weimi Bio-Tech Co., Ltd (“Weimi Bio-Tech”) successfully obtained the EU CE certificate.

Illumina said on Tuesday that it has added a companion diagnostic indication to its in vitro diagnostic TruSight Oncology (TSO) Comprehensive (EU) test.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal second quarter revenues rose 5 percent year over year.

On May 23, New Horizon Health (6606.HK) and Prenetics Group Limited (NASDAQ: PRE, Prenetics for short) jointly announced a strategic cooperation to promote the listing of cancer early screening product ColoClear in Hong Kong and "going overseas" to Southeast Asia.

Google confirmed the hire and said Bakul Patel will report to Linda Peters, vice president of quality, regulatory and safety at Google Health.

DiaSorin's Luminex on Friday announced it has obtained CE marking for its Aries Flu A/B & RSV+SARS-CoV-2 Assay, a multiplex molecular panel that detects four common respiratory viruses and their underlying respiratory infections.

Nanomix said on Friday that it has received the CE mark for its eLab COVID-19 antigen test which provides qualitative results in 15 minutes from an anterior nasal swab.